Among 193 CML-CP patients, the most frequently mutated genes were ASXL1, DNMT3A, and TET2, which is consistent with recent studies [14, 15, 25]. The gene discussed is TET2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.